-
Methodology for Estimating Equal Value Life-Year for Standard Three-State Partitioned Survival Models
Mar 10, 2025, 14:00 PM -
Economic Evaluations of Preventive Interventions for Self-Harm and Suicide: A Systematic Review
Mar 10, 2025, 14:00 PM -
Economic Burden of Non-Pharmacological Treatment in Amyotrophic Lateral Sclerosis in Brazil's Public Healthcare System: A 2022 Real World Cost Analysis
Mar 10, 2025, 14:00 PM -
Non-Invasive Tests (NITs) to Risk-Stratify Patients with Noncirrhotic Metabolic-Associated Steatohepatitis (MASH) in a Specialty Setting Eligible for Resmetirom: A Cost-Effectiveness Analysis from a U.S. Payer Perspective
Mar 10, 2025, 14:00 PM -
Characteristics of Patients With Bullous Pemphigoid in the US Medicare Population
Mar 10, 2025, 14:00 PM -
Cost-Effectiveness of Tolvaptan Vs. Angiotensin-Converting Enzyme Inhibitors for US Patients with Autosomal Dominant Polycystic Kidney Disease
Mar 10, 2025, 14:00 PM -
Novel Value Elements: Developing and Applying a Pragmatic Framework in Early Stages of Product Development
Mar 10, 2025, 14:00 PM -
The Most Heavily Managed Drug Categories on Part D Formularies
Mar 10, 2025, 14:00 PM -
Burden of Administration: Belamaf Based Combinations (BVd, BPd) Versus Carfilzomib Based Combinations (IsaKd, DKd, Kd)
Mar 10, 2025, 14:00 PM -
An Interim Analysis of the Burden of Influenza Infection on Health-Related Quality of Life and Work Productivity Among Adults in the United States
Mar 10, 2025, 14:00 PM -
Estimated Total Cost of Care (TCC) of First-Line (1L) Fixed-Duration BCL2i versus Treat-To-Progression BTKi Regimens in Patients with Chronic Lymphocytic Leukemia (CLL) in the United States (US): A Population-Based Model
Mar 10, 2025, 14:00 PM -
Hospital Resource Utilization and Estimated Costs Associated with Nipocalimab: Post-hoc Analysis of the Placebo-Controlled VIVACITY-MG3 Trial in Generalized Myasthenia Gravis
Mar 10, 2025, 14:00 PM -
Exploring Oral Skeletal Muscle Relaxant Therapy in Adult Poststroke Patients in the US
Mar 10, 2025, 14:00 PM -
Dual Inhibitor Identification for Mutated IDH1/2 To Reduce D-2-Hydroxyglutarate in Glioblastoma
Mar 10, 2025, 14:00 PM -
Blood Phenylalanine (Phe) Levels in Individuals With Phenylketonuria (PKU): A United States Electronic Health Records (US EHR) and Medical Notes Study
Mar 10, 2025, 14:00 PM -
Improve Analyst Accuracy in Systematic Literature Reviews Using Reliant Tabular and LLM-Based Relevance Scoring
Mar 10, 2025, 14:00 PM -
Real-World Evidence of Setmelanotide in Patients with Rare Melanocortin-4 Receptor Pathway Diseases: Baseline Findings from the RESTORE Longitudinal Survey Study
Mar 10, 2025, 14:00 PM -
Analysis of the Human Development Index by Innovation In Health, Through the Incorporation of New Technologies In Oncology: Preliminary Data in LMIC/LATAM/Brazil
Mar 10, 2025, 14:00 PM -
Predictors of Low Disease Activity/ Remission Amongst Rheumatoid Arthritis Patients Experiencing Inadequate Response to Biologic/ Targeted Synthetic Disease-Modifying Antirheumatic Drugs
Mar 10, 2025, 14:00 PM -
Evolving HTA and Potential EU HTAR Ripple Effects in the US: Insights From a Stakeholder Survey
Mar 10, 2025, 14:00 PM
